Table 1.
Baseline subjects demographics & characteristics
| Intervention Arm (n=149) | Control Arm (n=145) | |
|---|---|---|
| Number of subjects; n (%) | ||
| Male |
86 (57.7%) |
83 (57.2%) |
| Female |
63 (42.3%) |
62 (42.8%) |
| Age, years; Mean (SD) |
49.4 (11.1) |
48.8 (9.9) |
| Race; Asian |
149 (100.0) |
145 (100.0) |
| Weight, kg; Mean(SD) |
72.7 (15.2) |
70.2 (15.1) |
| Height, cm; Mean (SD) |
160.2 (8.2) |
159.6 (9.3) |
| Body mass index, kg/m2; Mean (SD) |
28.2 (4.9) |
27.4 (4.9) |
| Mean duration of dyslipidaemia since onset (years) |
0.6 |
0.6 |
| Cardiovascular risk group a; n (%) | ||
| Group I |
14 (9.4) |
24 (16.6) |
| Group II |
87 (58.4) |
74 (51.0) |
| Group III |
48 (32.2) |
47 (32.4) |
| Age risk; n (%) | ||
| Male aged >45; Female aged >55 |
72 (48) |
60 (41) |
| Male aged ≤45; Female aged ≤55 |
77 (52) |
85 (59) |
| Family history b; n (%) | ||
| Yes |
29 (19) |
32 (22) |
| No |
120 (81) |
113 (78) |
| Blood pressure ≥ 140/90 mm Hg or antihypertensive medication at baseline; n (%) | ||
| Yes |
89 (60) |
88 (61) |
| No |
60 (40) |
57 (39) |
| Diabetes Mellitus; n (%) | ||
| Yes |
47 (32) |
47 (32) |
| No |
102 (68) |
98 (68) |
| CHD or CHD risk equivalent a; n (%) | ||
| Yes |
1 (1) |
1 (1) |
| No |
148 (99) |
144 (99) |
| Smoking Status | ||
| Never smoked |
101 (68) |
97 (67) |
| Ex-smoker |
13 (9) |
19 (13) |
| Current smoker | 35 (23) | 29 (20) |
COACH = Counselling and Advisory Care for Health; SD = standard deviation; CHD = coronary heart disease; PCP = Primary Care Physicians; PCP-NE = Primary Care Physicians assisted by Nurse Educators.
a Group I: subjects with dyslipidaemia with no other cardiovascular risk factors; Group II: subjects with dyslipidaemia with at least 1 additional cardiovascular risk factor, excluding CHD and DM; Group III: subjects with dyslipidaemia with CHD or CHD risk equivalent.
b A history of premature coronary heart disease in a first-degree relative (parent or sibling). If the afflicted family member was male, premature coronary heart disease would have occurred before age 55, and if female, before age 65.